Via 5-year survival analysis, we found that six genes (LCAT, ACSM3, IGF1, SRD5A2, THRSP, and ACADS) were associated with the prognosis of HCC patients. This evidence concerns the gene SRD5A2 and hepatocellular carcinoma.